IA-CascadeOpen13843COMPETITIVE_CALL

PRECISEU Open Call: Joint Interregional Projects (JIP)

PRECISEU Open Call

Per project€3M

Call envelope€12M

1 phase

Deadline:2026-06-14

💡

Strategic Analysis

The PRECISEU Open Call provides financial support to third parties for Joint Interregional Projects (JIPs), aiming to strengthen interregional innovation ecosystems in personalised medicine. This Horizon Europe project has an overall budget of €22,730,100, with €11,570,000 allocated to the open call.

The call follows a single-stage application procedure, launched on 13 April 2026, with a submission deadline of 14 June 2026. Results are expected by 31 July 2026, and projects can start as early as 1 October 2026, with a latest end date of 31 March 2029.

Projects are expected to be Innovation Action-like, focusing on deep-tech innovation in advanced therapeutics and health data for personalised medicine, typically at Technology Readiness Levels 6 to 8. The maximum financial contribution per project is €3,000,000, and per single legal entity is €600,000.

Scope Activities (7)

SC01

Genuine European and interregional project logic

SC02Eliminating

Deep-tech innovation and experimental development at TRL 6-8

SC03

Address Advanced Therapeutics topic

SC04

Address Health Data for Personalised Medicine topic

SC05

Include a clear regulatory path to market

SC06Eliminating

Ensure patient benefit and equity in PM

SC07Eliminating

Promote cross-regional innovation alliances and knowledge transfer

Expected Outcomes (12)

EO01

Increased innovation co-investments

EO02

Increased participation in technology and industrial value chains

EO03

Increased collaboration in deep-tech and PM field

EO04

Strengthened positioning of European regions in precision health and deep tech

EO05

Contribution to EU's strategic goals in health innovation

EO06

Efficient knowledge transfer and co-development of solutions

EO07

Advancement in deep tech innovation

EO08

Acceleration of cutting-edge developments in ATMPs and health data applications

EO09

Strengthened research and development efforts

EO10

Strengthened regulatory readiness of funded solutions

EO11

Strengthened use of health data for clinical applications

EO12

Increased access of ATMPs to market and patients